Learning Objectives

• Describe the relationship between body mass index and both prevalent and incident asthma.
• Describe the predominant physiologic consequence of obesity on pulmonary function.
• Explain a mechanism by which obesity might cause or worsen asthma.

Target Audience

This activity is intended for Primary Care Physicians, Family Practitioners, Registered Nurses, Physician Assistants, Nurse Practitioners and affiliated health care professionals.

Accreditation

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

National Jewish Health designates this educational activity for a maximum of .75 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

National Jewish Health is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 12724. This program is approved for 1.0 Nursing Contact Hours.

Participating Faculty

David A. Beuther, MD, FCCP
Assistant Professor, Department of Medicine
Director of Medical Informatics
National Jewish Health
University of Colorado Denver Health Sciences Programs

Disclosure Information Listed for CME Content Development and Approval Committee and Participating Program Faculty

In accordance with the Accreditation Council for Continuing Medical Education, National Jewish Health requires that all program faculty, content developers, CME approval committee, and medical writers in a position to control the content of this activity are expected to disclose any or no significant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.

Significant financial interest is defined as receiving, or in the past twelve months having received, a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., Stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.

All CME Educational Activities sponsored by National Jewish Health are reviewed by our faculty CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

Key:
A Advisory Board   B Board of Directors   C Consultant   E Employee
F Founder   I Investigator   O Other   SP Speaker   SH Stockholder

David Beuther, MD, FCCP
SP AstraZeneca

Harold S. Nelson, MD
C - Abbott Laboratories, AstraZeneca, Boehringer-Ingelheim, Dey Laboratories, Dynavax Technologies, Dyson, Genentech/Novartis, GlaxoSmithKline, Johnson & Johnson, MediciNova, Schering-Plough, Sepracor, Teva
I - Altana, AstraZeneca, Boehringer-Ingelheim, Ception, Genentech, Novartis, Schering-Plough, Sepracor, Wyeth
SP - AstraZeneca, GlaxoSmithKline

Elaine Schwartz, MD
Has no significant financial interest to report

Michael Schwartz, MD
Has no significant financial interest to report

Richard Weber, MD
I - GlaxoSmithKline, Novartis, Pfizer
SP - AstraZeneca, sanofi-aventis, Schering-Plough

This program is sponsored by